Map the system. Preserve the evidence. Test the handoff.
The current guidance frames confidence in production and quality-system software around intended use, risk, appropriate assurance activity, issues, and retained evidence—not documentation volume.
FDA's scope guidance requires a buyer to identify applicable predicate rules, electronic records, reliance, signatures, copies, and retention before evaluating controls.
The guidance connects complete data to metadata, audit trails, access, processing, review, investigation, and retained records across instruments and applications.
FDA's scope guidance requires a buyer to identify applicable predicate rules, electronic records, reliance, signatures, copies, and retention before evaluating controls.
The guidance connects complete data to metadata, audit trails, access, processing, review, investigation, and retained records across instruments and applications.
The official annex connects risk, suppliers, validation, operation, change, security, incidents, continuity, and archiving in one computerized-system lifecycle.
The regulator's publication page preserves its GxP guidance while noting that OECD Advisory Document No. 22 takes precedence for GLP data integrity.
The standard places software-supported records inside a wider system of impartiality, competence, resources, methods, equipment, sampling, handling, technical records, reporting, and improvement.
The official standard record helps device and platform teams compare service definitions, commands, properties, metadata, and communication while leaving safety, method, data, and operating assurance separate.
A useful LIMS review traces request, sample, aliquot, specification, method, work assignment, result, exception, approval, report, and retained history. ELN and data-platform overlap does not erase that operating center.
Read the market record →Experiment authoring, entities, protocols, observations, analysis, collaboration, signatures, and intellectual-property records create a different decision surface from high-throughput sample operations.
Read the market record →Raw acquisition files, processed results, metadata, audit records, semantic models, methods, and derived datasets need explicit ownership. Archive, processing, and reuse are related but not interchangeable.
Read the market record →Worklists, device identity, method version, acquisition, transfer, exception, result review, and custody should survive the handoff among LES, CDS, LIMS, instruments, robotics, and enterprise systems.
Read the market record →Laboratory-system evidence is decision-useful only when the market label, authoritative record, configured workflow, scientific data, technical control, accountable reviewer, and unresolved boundary remain visible.
Laboratory-system evidence is decision-useful only when the market label, authoritative record, configured workflow, scientific data, technical control, accountable reviewer, and unresolved boundary remain visible.
Laboratory-system evidence is decision-useful only when the market label, authoritative record, configured workflow, scientific data, technical control, accountable reviewer, and unresolved boundary remain visible.
Laboratory-system evidence is decision-useful only when the market label, authoritative record, configured workflow, scientific data, technical control, accountable reviewer, and unresolved boundary remain visible.
Laboratory-system evidence is decision-useful only when the market label, authoritative record, configured workflow, scientific data, technical control, accountable reviewer, and unresolved boundary remain visible.
Laboratory-system evidence is decision-useful only when the market label, authoritative record, configured workflow, scientific data, technical control, accountable reviewer, and unresolved boundary remain visible.
The research connects the provider market, normalized capabilities, authority records, operating domains, and source limitations rather than presenting a score or universal winner.
Read the report →